BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2173840)

  • 1. Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.
    Quintana J
    Psychiatry Res; 1990 Sep; 33(3):229-42. PubMed ID: 2173840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations.
    Quintana J
    J Affect Disord; 1992 Feb; 24(2):55-62. PubMed ID: 1541767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal platelet 5-hydroxytryptamine uptake and imipramine binding in postnatal dysphoria.
    Hannah P; Adams D; Glover V; Sandler M
    J Psychiatr Res; 1992 Jan; 26(1):69-75. PubMed ID: 1313874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced inhibitory effect of imipramine on radiolabeled serotonin uptake into platelets in geriatric depression.
    Slotkin TA; Whitmore WL; Barnes GA; Krishnan KR; Blazer DG; Knight DL; Nemeroff CB
    Biol Psychiatry; 1989 Mar; 25(6):687-91. PubMed ID: 2538161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
    Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
    Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
    Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
    J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet serotonin uptake dynamic changes in depression: effects of long-term imipramine treatment and clinical recovery.
    Quintana J
    J Affect Disord; 1989; 16(2-3):233-42. PubMed ID: 2522122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood platelets in psychopharmacological research.
    Rotman A
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):135-51. PubMed ID: 6310688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions.
    Schneider LS; Severson JA; Chui HC; Pollock VE; Sloane RB; Fredrickson ER
    Psychiatry Res; 1988 Sep; 25(3):311-22. PubMed ID: 2847206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.
    DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S
    Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
    Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
    Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic effects of desmethylimipramine treatment on platelet serotonin uptake in depressed patients: a comparison with imipramine.
    Rausch JL; Moeller FG
    Psychiatry Res; 1991 Mar; 36(3):299-305. PubMed ID: 2062971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seasonal variation of platelet serotonin uptake and 3H-imipramine binding in normal and depressed subjects.
    Egrise D; Rubinstein M; Schoutens A; Cantraine F; Mendlewicz J
    Biol Psychiatry; 1986 Mar; 21(3):283-92. PubMed ID: 3004612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet 3H-clonidine and 3H-imipramine binding and plasma cortisol level in depression.
    Takeda T; Harada T; Otsuki S
    Biol Psychiatry; 1989 May; 26(1):52-60. PubMed ID: 2541808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet markers of suicidality.
    Meltzer HY; Arora RC
    Ann N Y Acad Sci; 1986; 487():271-80. PubMed ID: 3471162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet serotonin uptake and 3H-imipramine binding in panic disorder.
    Norman TR; Sartor DM; Judd FK; Burrows GD; Gregory MS; McIntyre IM
    J Affect Disord; 1989; 17(1):77-81. PubMed ID: 2544638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.